Table 1. Viral suppression at six months among children and adolescents with HIV newly initiated on ART during January 2017 to 30 September 2019 at Mpilo Central Hospital, Bulawayo, Zimbabwe.
| Overall
(0–19 years) |
Children
(0–9 years) |
Adolescents
(10–19 years) |
||||
|---|---|---|---|---|---|---|
| N | (%) | N | (%) | N | (%) | |
| Total | 295 | (100) | 196 | (100) | 99 | (100) |
| Virally unsuppressed * | 52 | (18) | 38 | (19) | 14 | (14) |
| Virally suppressed ** | 161 | (54) | 116 | (59) | 45 | (46) |
| Unknown *** | 82 | (28) | 42 | (22) | 40 | (40) |
Col%
HIV=human immunodeficiency virus; ART=antiretroviral therapy.
*repeat VL≥1000 copies per ml despite enhanced adherence counseling; **VL<1000 at six months or after repeat VL testing (post enhanced adherence counseling); ***not fitting into any of the above two categories, represents children or adolescents that were lost at any point in the cascade.